Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
4407710
Author(s)
Laubli, H.; Tzankov, A.; Juskevicius, D.; Degen, L.; Rochlitz, C.; Stenner-Liewen, F.
Author(s) at UniBasel
Rochlitz, Christoph
Year
2016
Title
Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder
Journal
Leukemia & Lymphoma
Volume
57
Number
4
Pages / Article-Number
945-8
Keywords
Adult; B-Lymphocytes/*pathology; Biopsy; Epstein-Barr Virus Infections/complications; Female; Genomics/methods; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Immunohistochemistry; Lymphoproliferative Disorders/*diagnosis/*drug therapy/etiology; Remission Induction; Thalidomide/*analogs & derivatives/therapeutic use; Tomography, X-Ray Computed; Treatment Outcome
Mesh terms
Adult; B-Lymphocytes, pathology; Biopsy; Epstein-Barr Virus Infections, complications; Female; Genomics, methods; Hematopoietic Stem Cell Transplantation, adverse effects; Humans; Immunohistochemistry; Lenalidomide; Lymphoproliferative Disorders, etiology; Remission Induction; Thalidomide, therapeutic use; Tomography, X-Ray Computed; Treatment Outcome
Publisher
TAYLOR & FRANCIS LTD
ISSN/ISBN
1029-2403
edoc-URL
https://edoc.unibas.ch/62419/
Full Text on edoc
No
Digital Object Identifier DOI
10.3109/10428194.2015.1083563
PubMed ID
http://www.ncbi.nlm.nih.gov/pubmed/26295731
ISI-Number
WOS:000372196100029
Document type (ISI)
Letter
MCSS v5.8 PRO. 0.342 sec, queries - 0.000 sec
©Universität Basel | Impressum
|
07/05/2024
Research Database / FORSCHUNGSDATENBANK
